With the analysis among 206 patents, we discovered top 69 key players by total patent application. Espervita Therapeutics, Inc., AEterna Zentaris GmbH, International Institute of Cancer Immunology, Inc. are dominant in this area. They take 23.79% of the total patent filing.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Hessen, Germany
Patent: 19
International Institute of Cancer Immunology, Inc.
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 10
Cambridgeshire, United Kingdom
Patent: 8
Secarna Pharmaceuticals Gmbh & Co.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 6
Galvanize Therapeutics, Inc.
California, United States
Patent: 6
Nanjing Tengchen Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 6
With the analysis among 30 patents, we discovered top 4 start-ups by total patent application. Espervita Therapeutics, Inc., Galvanize Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Galvanize Therapeutics, Inc.
California, United States
Patent: 6
Institut National de la Santé et de la Recherche Médicale
Beijing Geneplus Technology Co., Ltd.
Beijing Shi, China
Patent: 1
With the analysis among related 195 patents applied in the last 5 years. We discover 68 most active companies in this area. The fast-growing Espervita Therapeutics, Inc., Sumitomo Pharmaceuticals Co., Ltd., International Institute of Cancer Immunology, Inc. take 20.51% of patent filing during this period.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 10
International Institute of Cancer Immunology, Inc.
Cambridgeshire, United Kingdom
Patent: 8
Hudson Institute of Medical Research
Victoria, Australia
Patent: 7
Secarna Pharmaceuticals Gmbh & Co.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 6
Galvanize Therapeutics, Inc.
California, United States
Patent: 6
Nanjing Tengchen Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 6
Yonsei Industry-Academic Cooperation Foundation
With the analysis among related 195 patents in last 5 years, we discover 66 new entrants. Espervita Therapeutics, Inc., Sumitomo Pharmaceuticals Co., Ltd., International Institute of Cancer Immunology, Inc. are the most active new entrants in this area.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 10
International Institute of Cancer Immunology, Inc.
Cambridgeshire, United Kingdom
Patent: 8
Hudson Institute of Medical Research
Victoria, Australia
Patent: 7
Secarna Pharmaceuticals Gmbh & Co.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 6
Galvanize Therapeutics, Inc.
California, United States
Patent: 6
Nanjing Tengchen Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 6
Yonsei Industry-Academic Cooperation Foundation
With the analysis among 75 patents, we discovered top 22 universities and scientific research institutions by total patent application. University of Tokyo, National Yang Ming Chiao Tung University, Queensland University of Technology are dominant in this area. They take 22.67% of the total patent filing.
National Yang Ming Chiao Tung University
Taiwan Province, China
Patent: 5
Queensland University of Technology
Queensland, Australia
Patent: 4
Kanagawa-ken, Japan
Patent: 4
Shandong Sheng, China
Patent: 3
Dresden University of Technology
Sachsen, Germany
Patent: 3
Centre Hospitalier Universitaire de Bordeaux
Bretagne, France
Patent: 2
The Johns Hopkins University
Texas, United States
Patent: 1